Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer
Kaitlin R. McCarter, Senada Arabelovic, Xiaosong Wang, Taylor Wolfgang, Kazuki Yoshida, Grace Qian, Emily Kowalski, Kathleen M.M. Vanni, Nicole R. LeBoeuf, Elizabeth I. Buchbinder, Lydia Gedmintas, Lindsey A. MacFarlane, Deepak A. Rao, Nancy A. Shadick, Ellen M. Gravallese, Jeffrey A. Sparks
Topics & Concepts
MedicineRheumatoid arthritisInternal medicineCohortHazard ratioCancerProportional hazards modelRetrospective cohort studyOncologyConfidence intervalCancer Immunotherapy and BiomarkersRheumatoid Arthritis Research and TherapiesInflammatory Biomarkers in Disease Prognosis